Strategies to improve myocardial protection during extracorporeal circulation

Shock

Volumn 16, Issue SUPPL., 2001, Pages 20-23

  Menasché, Philippe ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Cardiac surgery; Extracorporal circulation; Myocardial protection; Review

Indexed keywords

SODIUM PROTON EXCHANGE PROTEIN;

CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; HEART ARREST; HEART DISEASE; HEART INFARCTION PREVENTION; HUMAN; INFLAMMATION; METHODOLOGY; POSTOPERATIVE COMPLICATION; REVIEW;

CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; EXTRACORPOREAL CIRCULATION; HEART ARREST, INDUCED; HEART DISEASES; HUMAN; INFLAMMATION; ISCHEMIC PRECONDITIONING, MYOCARDIAL; POSTOPERATIVE COMPLICATIONS; SODIUM-HYDROGEN ANTIPORTER;

EID: 0040620672     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200116001-00005     Document Type: Review

References (24)

1. O'Connor GT, Birkmeyer JD, Dacey LJ, Quinton HB, Marrin CA, Birkmeyer NJ, Morton JR, Leavitt BJ, Maloney CT, Hernandez F, Clough RA, Nugent WC, Olmstead EM, Charlesworth DC, Plume SK: Results of a regional study of modes of death associated with coronary artery bypass grafting. Ann Thorac Surg 66:1323-1328, 1998.
2. Hendry PJ, Masters RG, Haspect A: Is there a place for cold crystalloid cardioplegia in the 1990s? Ann Thorac Surg 58:1690-1694, 1994.
3. Khuri SF, Warner KG, Josa M, Butler M, Hayes A, Hanson R, Siouffi S, Barsamian EM: The superiority of continuous cold blood cardioplegia in the metabolic protection of the hypertrophied human heart. J Thorac Cardiovasc Surg 95:442-454, 1988.
4. Loop FD, Higgins TL, Panda R, Pearce G, Estafanous FG: Myocardial protection during cardiac operations: decreased morbidity and lower cost with blood cardioplegia and coronary sinus perfusion. J Thorac Cardiovasc Surg 104:608-618, 1992.
5. Tomasco B, Cappiello A, Fiorilli R, Leccese A, Lupino R, Romiti A, Tesler UF: Surgical revascularization for acute coronary insufficiency: analysis of risk factors for hospital mortality. Ann Thorac Surg 64:678-683, 1997.
6. Quintilio C, Voci P, Bilotta F, Luzi G, Chiarotti F, Acconcia MC, Mercanti C, Marino B: Risk factors of incomplete distribution of cardioplegic solution during coronary artery grafting. J Thorac Cardiovasc Surg 109:439-447, 1995.
7. Kaul TK, Agnihotri AK, Fields BL, Riggins LS, Wyatt DA, Jones CR: Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 111:1001-1012, 1996.
8. Rashid A, Jackson M, Page RD, Desmond MJ, Fabri BM: Continuous warm versus intermittent cold blood cardioplegia for coronary bypass surgery in patients with left ventricular dysfunction. Eur J Cardiothorac Surg 9:405-409, 1995.
9. Menasché P. Blood cardioplegia: Do we still need to dilute? Ann Thorac Surg 62:957-960, 1996.
10. Antunes PE, De Oliveira JF, Antunes MJ: Non-cardioplegic coronary surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 16: 331-336, 1999.
11. Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, Kishimoto T: Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91: 1520-1524, 1995.
12. Deng MC, Dasch B, Erren M, Möllhoff T, Scheld HH: Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann Thorac Surg 62:184-190, 1996.
13. Mehlhorn U, Allen SJ, Adams DL, Davis KL, Gogola GR, de Vivie ER, Laine GA: Normothermic continuous antegrade blood cardioplegia does not prevent myocardial edema and cardiac dysfunction. Circulation 92:1939-1946, 1995.
14. Liebold A, Keyl C, Birnbaum E: The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur J Cardiothorac Surg 15:340-345, 1999.
15. Birdi I, Caputo M, Hutter JA, Bryan AJ, Angelini GD: Troponin I release during minimally invasive coronary artery surgery. J Thorac Cardiovasc Surg 114:509-510, 1997.
16. Sternik L, Moshkovitz Y, Hod H, Mohr R: Comparison of myocardial revascularization without cardiopulmonary bypass to standard open heart techniques in patients with left ventricular dysfunction. Eur J Cardiothorac Surg 11:123-128, 1997.
17. Bergsland J, Hasnain S, Lajos TZ, Salerno TA: Elimination of cardiopulmonary bypass: a prime goal in reoperative coronary artery bypass surgery. Eur J Cardiothorac Surg 14:59-63, 1998.
18. Perrault LP, Menasche P, Peynet J, Paris B, Bel A, de Chaumaray T, Gatecel C, Touchot B, Bloch G, Moalic JM: On-pump, beating-heart coronary artery operations in high-risk patients: an acceptable trade off? Ann Thorac Surg 64:1368-1373, 1997.
19. Perrault LP, Menasche P, Bel A, de Chaumaray T, Peynet J, Mondry A, Olivero P, Emanoil-Ravier R, Moalic JM: Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg 112:1378-1386, 1996.
20. Mentzer RM Jr, Birjiniuk V, Khuri S, Lowe JE, Rahko PS, Weisel RD, Wellons HA, Barker ML, Lasley RD: Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg 229:643-650, 1999.
21. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasché P: Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 100(Suppl II):II340-II344, 1999.
22. + exchange inhibition versus ischemic preconditioning. Circulation 100: 2469-2472, 1999.
23. Boyle EM Jr, Kovacich JC, Canty TG Jr, Morgan EN, Chi E, Verrier ED, Pohlman TH: Inhibition of nuclear factor-κB nuclear localization reduces human E-selectin expression and the systemic inflammatory response. Circulation 98:II282-II288, 1998.
24. Sawa Y, Morishita R, Suzuki K, Kagisaki K, Kaneda Y, Maeda K, Kadoba K, Matsuda H: A novel strategy for myocardial protection using in vivo transfection of cis element "decoy" against NFκB binding site: evidence for a role of NFKB in ischemia-reperfusion injury. Circulation 96(Suppl II):II280-II285, 1997.